4 | VaccinesIBA
01/2014
-
06/2001 |
4 | Peptides (Polypeptides)IBA
07/2008
-
06/2001 |
4 | Proteins (Proteins, Gene)FDA Link
01/2007
-
05/2003 |
3 | AntigensIBA
12/2020
-
09/2001 |
3 | BBG2Na vaccineIBA
06/2000
-
04/2000 |
2 | Glucose (Dextrose)FDA LinkGeneric
01/2016
-
10/2015 |
2 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
-
05/2009 |
2 | CytokinesIBA
11/2011
-
06/2001 |
2 | Biomarkers (Surrogate Marker)IBA
07/2009
-
05/2006 |
2 | Proteasome Endopeptidase Complex (Proteasome)IBA
06/2009
-
01/2007 |
2 | Bortezomib (Velcade)FDA Link
06/2009
-
01/2007 |
2 | Diclofenac (SR 38)FDA LinkGeneric
02/2007
-
09/2003 |
2 | Analgesics (Analgesic Drugs)IBA
02/2007
-
01/2007 |
2 | Respiratory Syncytial Virus VaccinesIBA
06/2000
-
06/2000 |
1 | Pharmaceutical PreparationsIBA
03/2021 |
1 | Pheromones (Semiochemicals)IBA
01/2018 |
1 | Insulin (Novolin)FDA Link
01/2016 |
1 | SodiumIBA
10/2015 |
1 | Sodium-Glucose Transport ProteinsIBA
10/2015 |
1 | 6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
10/2015 |
1 | Sodium-Glucose Transporter 2 InhibitorsIBA
10/2015 |
1 | Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2014 |
1 | IronIBA
01/2014 |
1 | FrataxinIBA
01/2014 |
1 | Small Interfering RNA (siRNA)IBA
06/2013 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2012 |
1 | triphenyltetrazoliumIBA
04/2012 |
1 | Evans Blue (Blue, Evans)FDA Link
04/2012 |
1 | Mitochondrial Permeability Transition PoreIBA
04/2012 |
1 | Desflurane (I 653)FDA Link
04/2012 |
1 | Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
04/2012 |
1 | Alcian BlueIBA
03/2011 |
1 | AntipyreticsIBA
06/2010 |
1 | Cefuroxime (Zinacef)FDA LinkGeneric
04/2010 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
04/2010 |
1 | UbiquitinIBA
06/2009 |
1 | Peptide Hydrolases (Proteases)FDA Link
06/2009 |
1 | polyarginineIBA
07/2008 |
1 | SMAC peptideIBA
07/2008 |